[Federal Register Volume 83, Number 87 (Friday, May 4, 2018)]
[Notices]
[Page 19790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09424]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Clinical Trials and
Translational Research Advisory Committee was renewed for an additional
two-year period on April 14, 2018.
It is determined that the National Cancer Institute Clinical Trials
and Translational Research Advisory Committee is in the public interest
in connection with the performance of duties imposed on the National
Cancer Institute and National Institutes of Health by law, and that
these duties can best be performed through the advice and counsel of
this group.
Inquiries may be directed to Claire Harris, Acting Director, Office
of Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail Stop Code 4875), [email protected] or Telephone
(301) 496-2123.
Dated: April 30, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-09424 Filed 5-3-18; 8:45 am]
BILLING CODE 4140-01-P